ConnectiveRx Executive and Leadership Team

Harry Totonis, the Chief Executive Officer & Chairman at ConnectiveRx, directs the overarching strategic vision and corporate governance for the technology-enabled biopharmaceutical services company. Totonis guides the organization's mission to provide critical patient and provider support, access, and adherence solutions for specialty and branded medications. Overseeing all executive functions, Totonis ensures alignment with the company's founding principles and market objectives. This leadership role involves driving innovation in patient support programs and expanding the company's reach within the biopharmaceutical sector. By fostering key relationships with stakeholders and partners, Harry Totonis solidifies ConnectiveRx's position as a leader in enhancing medication access and adherence across North America. The Chairman's responsibilities include setting long-term goals and ensuring sustainable growth and operational excellence.

Brett Weinblatt, the Chief Financial Officer at ConnectiveRx, directs all financial operations and fiscal strategy for the biopharmaceutical services company. Weinblatt manages financial planning, budgeting, and reporting, ensuring the company's financial health and stability. This role involves overseeing capital allocation, investment strategies, and risk management to support ConnectiveRx's growth objectives. By analyzing financial performance and market trends, the Chief Financial Officer provides critical insights to guide strategic decision-making across the organization. Brett Weinblatt's expertise is vital in securing funding and managing financial relationships, particularly as the company expands its patient and provider support solutions. Weinblatt's stewardship of financial resources underpins the company's capacity to innovate and serve the biopharmaceutical sector effectively throughout the United States.

Gwyn Plaskon, the Chief Operating Officer at ConnectiveRx, executes the company's operational strategies to deliver patient and provider support solutions. Plaskon manages the day-to-day functions critical to the seamless delivery of access and adherence programs for specialty and branded medications. This involves optimizing service delivery across all operational departments, ensuring efficiency and high-quality outcomes for patients and pharmaceutical partners. Overseeing the integration of technology-enabled services, the Chief Operating Officer drives process improvements and scalability. Gwyn Plaskon's leadership ensures that ConnectiveRx consistently meets the complex needs of the biopharmaceutical industry, particularly in regions across the United States. By focusing on operational excellence, Plaskon directly contributes to the company's ability to enhance medication adherence and patient support.

Snehal Desai, the Chief Technology Officer at ConnectiveRx, architects the company's technology strategy and oversees all digital infrastructure supporting patient and provider services. Desai leads the development and implementation of innovative technology solutions that enhance access and adherence for specialty medications. This involves managing the company's technology roadmap, ensuring robust data security, and driving digital transformation initiatives. By leveraging cutting-edge technology, the Chief Technology Officer optimizes the efficiency and effectiveness of ConnectiveRx's service offerings across its operational footprint. Snehal Desai's focus on technological advancement is crucial for maintaining the company's competitive edge in the biopharmaceutical services market. Desai's leadership ensures that ConnectiveRx's technology platforms are scalable, reliable, and aligned with the evolving needs of the industry.

Mark Pawlak, the Chief People Officer at ConnectiveRx, leads human capital strategy and organizational development to foster a high-performing workforce. Pawlak oversees talent acquisition, employee engagement, and professional development programs designed to support the company's mission in biopharmaceutical services. This role involves cultivating a positive and inclusive company culture that attracts and retains top talent essential for delivering patient and provider support. By championing employee well-being and growth, the Chief People Officer ensures that ConnectiveRx's team is equipped to meet the dynamic demands of the market. Mark Pawlak's strategic approach to people management is fundamental to the company's operational success and its ability to innovate in patient access and adherence solutions across the United States.

Danielle Daly, the Chief Marketing & Communications Officer at ConnectiveRx, directs the company's brand strategy and external communications initiatives. Daly oversees the development and execution of marketing campaigns that highlight ConnectiveRx's expertise in patient and provider support for specialty medications. This involves managing public relations, digital marketing, and corporate communications to enhance brand visibility and market positioning. By articulating the company's value proposition, the Chief Marketing & Communications Officer drives engagement with key stakeholders, including pharmaceutical clients and healthcare professionals. Danielle Daly's leadership ensures that ConnectiveRx's message of improving access and adherence resonates effectively across the biopharmaceutical industry. Daly's strategic communication efforts bolster the company's reputation and support its growth objectives.